Autopsies of AD patients revealed reduced PI3K/AKT signaling activity in the frontal cortex, along with elevated levels of phosphorylated GSK-3β and abnormally hyperphosphorylated Tau (Ochiai et al., 2021). This evidence concerns the gene AKT1 and Alzheimer disease.